Conference icon

Conference

Traficet-EN, an oral CCR9-specific antagonist, induces high levels of remission in the open-label phase of PROTECT-1 in Crohn's disease

Publication status:
Published

Actions


Authors


Hamilton, G More by this author
Johnson, D More by this author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Experimental Medicine Division, Clinical Medicine
Volume:
103
Pages:
S409-S409
Publication date:
2008-09-05
ISSN:
0002-9270
URN:
uuid:f91b4db4-be1e-4a21-83b5-1616afa21ded
Source identifiers:
66845
Local pid:
pubs:66845

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP